Patient-specific verification of intensity-modulated radiation therapy (IMRT) plans can be done by dosimetric measurements or by independent dose or monitor unit calculations. The aim of this study was the clinical evaluation of IMRT verification based on a fast Monte Carlo (MC) program with regard to possible benefits compared to commonly used film dosimetry.
Introduction
The intensity-modulated radiotherapy (IMRT) technique is currently the most advanced form of conformal radiotherapy and holds great promise for improving radiotherapy both through increased tumor control probability and decreased treatment toxicity. As with all treatment modalities, verification and characterization measurements are required before clinically implementing IMRT. Moreover, it is apparent that comprehensive quality assurance (QA) is essential for IMRT due to the non-intuitive nature of treatment planning. Rec-ommendations and guidelines for determining the appropriate use of IMRT, beginning an IMRT program, and maintaining the adequate QA to safely use IMRT are given in recently published and national regulatory reports [1] [2] [3] [4] . Each institution's QA program should be designed to encompass the entire IMRT process, i.e. commissioning and validation of the dose calculation algorithm, data transfer from the treatment planning system (TPS) to the linac verify and record (V&R) system, and the delivery process itself. After gaining experience, the IMRT QA is usually subdivided into a multileaf collimator (MLC)/linac-specific QA part and a patient-specific QA part. Both parts are parallel procedures and do not interfere directly [5] . When going this way, patient-specific verification of IMRT plans can be done by dosimetric measurements or by independent dose or MU calculations. Dosimetric measurements typically comprise two types of checks for pre-treatment QA: single-beam verification and total-plan verification. In both cases, the patient's IMRT plan is transferred to a phantom and calculations are done at the points or depths of interest. Due to the characteristics of IMRT dose distributions including complex 3D treatment volume geometries, the precise characterization of these distributions using only point dosimeters is not practical. Mainly a comparison of two-dimensional calculated and measured data is performed. As a two-dimensional integrating dosimetry medium, radiographic films (an EDR-2 in particular) [6, 7] or less commonly, radiochromic films [8] are nearly ideal for such measurements due to their very good resolution.
Nevertheless, a multitude of alternative methods for patient dose validation, e.g. large scale 2D ion chamber or diode arrays as well as flat-panel electronic portal imaging devices (EPID) have been studied [9] [10] [11] . However, perhaps because of its familiarity and apparent simplicity, radiographic film remains one 3 of the most common means for validating patient IMRT treatments through dose measurements. The use of radiographic films for dosimetry is described in detail in the AAPM Report 69 [12] .
Methods based on Monte Carlo (MC) algorithms have been used for external beam radiotherapy dose calculation [13] . It is well accepted that MC is the most accurate dose calculation method, since it can precisely model realistic radiation transport through the accelerator treatment head, the MLC and the patient anatomy. Accordingly, MC has been regarded as a powerful tool to obtain the accurate dose distributions in the (heterogeneous) patient. Efforts have been made to implement MC in clinical treatment planning and plan verification [14] , and suitable TPS are currently put on the market. There have been several fast MC codes developed, such as VMC/XVMC [15, 16] , DPM [17] , MCV [18] or MCDOSE [19] . These codes employ a variety of variance reduction techniques and achieve reduced CPU time compared to ordinary EGSnrc calculations. Prior to clinical use, however, the calculation method should be commissioned against phantom measurements and the treatment planning system algorithm. 
IMRT treatment plans
Plans for 25 patients with head-and-neck cancer receiving step-and-shoot IMRT with a Siemens Primus R linear accelerator (1 cm projected leaf width at the isocenter distance and 6 MV photons) were used in the study. IMRT plans were based on a uniformly distributed seven-field arrangement except for two plans which had five fields, and were optimized with Oncentra 
Monte Carlo simulations
The Monte Carlo simulations were performed using XVMC [20] , into which the VEF model [21] is implemented in conjunction with geometry parameters for the patient-dependent portion of the treatment head (MLC and jaws).
Since the commissioning procedure of this model is based on standard measurements in air but only on one depth dose in water for a reference field size, additional measurements in water were carried out to verify the model and its parameters. Percentage depth dose curves for standard field sizes and beam profiles in various depths were compared [22] . As an example, Figure 1 
Verification procedures
After an IMRT treatment plan was accepted, it was recalculated using identical beam settings but replacing the patient with a cylindrical polyethylene (PE) phantom (diameter 20 cm, height 20 cm). Such a phantom is easily accessible to dosimetry by radiographic films and point measurements [7] . It is possible to mark the coordinate system onto the films with a guided needle for data correlation and evaluation with IMRT software (PTW-VeriSoft Except for two film verification measurements, the mean dose deviations remain within a confidence limit of 5 % proposed for treatment plan acceptance [24] . Additionally, the highlighted region in the figure marks the range for the MC dose calculation results. Table 1 Regarding film dosimetry, there are several challenges in obtaining high-quality dosimetric results, namely, the dependence of optical density on photon energy, field size, depth, film batch sensitivity differences, film orientation, processing conditions, and scanner performance [7, 12] . Based on film measurement results obtained in this study, an aimed confidence limit of 3 % dose deviation (with respect to the prescribed dose) or 6 cGy, as suggested in Ref. [27] , was only fulfilled for 16 out of 25 IMRT cases in the high-dose region. A significant lower uncertainty and dose deviation of less than 3 % for all plans compared to the PB based TPS could be achieved when applying verification calculations with XVMC/VEFM; however, there were still slight differences. It is striking that the TPS with its PB algorithm had a tendency to overestimate the dose in the high dose area calculated with the MC program. These deviations may be attributed to computational uncertainty of the PB algorithm and to limitations in the accuracy of calculations at field edges and out of field [28] .
In addition, discrepancies in output factor measurements for small fields up to 5 % for MC, and similar accuracy for PB calculations in a water phantom might be taken into consideration. Same uncertainties have to be kept in mind when comparing MC calculated dose distribution to film measurements. In addition to the challenge in context to correct film dosimetry, these difficulties contribute to the observed deviations between MC and film dose distributions. Comparing MC and TPS PB with film dosimetry, the variance in dose difference (σ 2 = 0.001), however, is very similar for both comparisons.
As commonly known, Monte Carlo simulations are proven to be the gold standard in radiation dose calculation. Nevertheless, there are a few aspects that need careful consideration.
While the total time for MC simulations is comparable to film dosimetry, no extra time on the linac is required. Moreover, the manpower requirements for MC dose calculation are reduced to the DICOM file export from the TPS and import into the MC program. Verification calculations though will not detect errors in the IMRT delivery process. For this reason, independent calculations in addition to measurements of single dose points should be part of a rigorous control of the dose delivery system. However, it is to be noted that there are also other promising approaches, e.g. the log file based Monte Carlo simulations [29] . The authors suggest to use this method as an initial IMRT QA procedure to screen the plans, and the measurement based methods as a second procedure only when necessary.
Independent dose calculations (and dosimetric measurements) are typically performed in a homogeneous verification phantom. Hence, the influence of inhomogeneities present in the patient is not taken into account. Several studies, however, have shown the limitations of PB algorithms in heterogeneous media [30, 31] . The PB algorithm produces large errors for the dose in the vicinity of interfaces and within low-density regions. In contrast, XVMC/VEFM calculations are very close to measurements even in the low-density area [31] , which may be important when calculating dose to inhomogeneous volumes such as the head-and-neck region studied in this work. Further research is needed to investigate these effects on the dose distribution in the (heterogeneous) patient and to make use of MC simulations as verification tool based on the patient CT data set.
Conclusion
One should keep clearly in mind that dosimetric measurements are timeconsuming and only verify the dose in a phantom geometry. Discrepancies between planar measurements and calculations may be difficult to interpret in terms of the clinical significance on a patient-by-patient basis. Independent monitor unit or dose calculations offer an alternative to dose measurements.
Monte Carlo is becoming fast enough to be used in clinics with the capability of accurate dose computations [32] [33] [34] [35] . Once a calculation method is properly verified, significant time can be saved when compared to measurements. However, additional QA checks are needed to verify accurate transfer of patient data and accurate delivery. Thus, a more stringent machine and MLC QA needs to be considered. In this context, deficiency inevitably lead to differences between calculated and measured dose distributions. As mentioned in the introduction, dosimetric plausibility checks in terms of point-dose measurements are considered appropriate. Dose calculation inaccuracies due to use of approximation algorithms like pencil beam or collapsed cone can potentially be detected by MC simulations of the treatment plan in the patient itself instead of in a homogeneous phantom. The 3D dose verification procedure dealing with this issue is currently under investigation and will be reported.
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